{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:35:23Z","timestamp":1761510923133},"reference-count":10,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.vaccine.2009.02.049","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T10:35:12Z","timestamp":1235558112000},"page":"2408-2409","source":"Crossref","is-referenced-by-count":21,"title":["Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy"],"prefix":"10.1016","volume":"27","author":[{"given":"Anna H.","family":"Roukens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann C.","family":"Vossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap T.","family":"van Dissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.049_bib1","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever","author":"Monath","year":"2008"},{"issue":"25","key":"10.1016\/j.vaccine.2009.02.049_bib2","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.049_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2009.02.049_bib4","unstructured":"National Coordination Centre for Traveller's Health (LCR). National guidelines for vaccination and malaria prophylaxis for travellers. Amsterdam: LCR; 2008."},{"key":"10.1016\/j.vaccine.2009.02.049_bib5","first-page":"113","article-title":"Field studies on the immune response to 17D yellow fever virus. Relation to virus substrain, dose and route of inoculation","volume":"38","author":"Fox","year":"1943","journal-title":"Am J Hygiene"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.049_bib6","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered Yellow Fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.049_bib7","first-page":"113","article-title":"A simple micro-culture method for the study of group B arboviruses","volume":"40","author":"De Madrid","year":"1969","journal-title":"Bull World Health Organization"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.049_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AEM.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.049_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":"Comparison of the immunogenicity and safety of two yellow fever vaccines","volume":"60","author":"Lang","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.049_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm1757","article-title":"Mast cell activators: a new class of highly effective vaccine adjuvants","volume":"14","author":"McLachlan","year":"2008","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T03:57:46Z","timestamp":1589601466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":10,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0264410X09003089"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}